P937: PRECLINICAL DISCOVERY AND EARLY FINDINGS FROM THE PHASE 1, DOSE-ESCALATION STUDY OF WVT078, A BCMA-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH R/R MULTIPLE MYELOMA
Authors:
Open Access
- 23 June 2022
- journal article
- abstracts
- Published by Wiley in HemaSphere
- Vol. 6 (Suppl) , 827-828